Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

Abstract

We report a 10-year follow-up on 52 patients with raised levels of anticardiolipin antibodies (aCL) who were first seen at our tertiary referral centre in 1986. The clinical and serological features of these 52 patients are described. Thirty-one patients had the antiphospholipid syndrome (APS) in 1986. Nine of these patients (29%) had further thrombotic events during the follow-up period. Of the other 21 aCL positive patients without clinical manifestations of APS, 11 (52%) developed the syndrome over this period. Five patients (10%) died during the follow-up. Close monitoring of patients with connective tissue diseases and aCL is essential as the likelihood of developing antiphospholipid syndrome is high.

Keywords

antiphospholipid antibodies antiphospholipid syndrome thrombosis pregnancy loss

Get full access to this article

View all access options for this article.

References

Hughes GRV . The antiphospholipid syndrome: ten years on . Lancet 1993; 342: 341–344 .

Khamashta MA , Hughes GRV . Antiphospholipid antibodies and antiphospholipid syndrome . Curr Opin Rheumatol 1995; 7: 389–394 .

Harris EN , Gharavi AE , Patel BM , Hughes GRV . Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986 . Clin Exp Immunol 1987; 68: 215–222 .

Harris EN , Pierangeli S , Birch D. Anticardiolipin wet workshop report: Vth International Symposium on Antiphospholipid Antibodies . Am J Clin Pathol 1994; 101: 616–624 .

Vianna JL et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicentre study of 114 patients . Am J Med 1994; 96: 3–9 .

Ginsburg KS et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis . Ann Intern Med 1992; 117: 997–1002 .

Petri M et al. The Hopkins lupus cohort: a longitudinal study of predictors of thrombosis . Lupus 1994; 3: 361-361 .

Finazzi G et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry . Am J Med 1996; 100: 530–536 .

Perez-Vazquez ME , Villa AR , Drenkard C , Cabiedes J , Alarcon Segovia D. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus . J Rheumatol 1993; 29: 437–442 .

10.

Lockshin MD.

Which patients with antiphospholipid antibody should be treated and how?

Rheum Dis Clin North Am 1993; 19: 235–247 .

11.

Drenkard C , Villa AR , Alarcon-Segovia D , Perez-Vazquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus . J Rheumatol 1994; 21: 1067–1072 .

12.

Gulko PS et al. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlation, HLA associations and impact on survival . J Rheumatol 1993; 20: 1684–1693 .

13.

Khamashta MA et al. The management of thrombosis in the antiphospholipid antibody syndrome . N Engl J Med 1995; 332: 993–997 .